title: Granulocytic sarcoma: 32 cases and review of the literature.
abstract: Thirty-two cases of granulocytic sarcoma (GS) are reported in this paper. Age range was from 16 - 70 years. GS was accompanied by AML in 13 cases, ALL (My+) in one case, CML in 11 cases and MDS in two cases. GS was diagnosed simultaneously with leukemia in five cases and preceded the leukemia in eight. Lymph node and soft tissue were the most commonly detected localizations. Seven cases had first been diagnosed as NHL. Histopathologically blastic, immature and mature variants were found in 11, nine and 11 cases respectively and overall survival was shortest in the blastic type. Myeloperoxidase and lysozyme were found to be positive in 30 and 24 cases respectively. Therapy was radiation in five cases and surgery in three. Systemic chemotherapy was given to the cases. The clinical outcome of the patients after the diagnosis of GS was poor. GS is a unique entity; prognosis is poor but it is important to detect the signaling pathways associated with migration of myeloid cells to the extra-medullary tissues. The critical factors for detecting this interesting tumor are to be aware of this disease, cooperation between clinician and pathologist and the application of special stains to detect the myeloid origin.
authors.affiliation: Department of Oncology, Cukurova University Faculty of Medicine, Adana, Turkey. sepay@cu.edu.tr
authors.forename: Semra
authors.initials: S
authors.lastname: Paydas
authors.forename: Suzan
authors.initials: S
authors.lastname: Zorludemir
authors.forename: Melek
authors.initials: M
authors.lastname: Ergin
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D001706:Biopsy; D003937:Diagnosis, Differential; D005260:Female; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000628:therapy; D008228:Lymphoma, Non-Hodgkin / Q000628:therapy; D008297:Male; D008495:Medical Oncology / Q000379:methods; D008875:Middle Aged; D023981:Sarcoma, Myeloid / Q000175:diagnosis*; D033581:Stem Cell Transplantation; D016896:Treatment Outcome